Insider · CIK 0001478832

Bartizal Ken

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001478832

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-03-31	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Development Officer	AAward	+50K sh	—	—	50,000
2016-03-16	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Development Officer	AAward	+50K sh	—	—	50,000
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−16.6K sh	$12.21	−$202K	0
2013-09-11	Trius Therapeutics IncD Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−96.4K sh	—	—	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−6,395 sh	$12.21	−$78.1K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−40K sh	$10.00	−$400K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−75K sh	$8.70	−$653K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−90K sh	$7.37	−$663K	0
2013-07-01	Trius Therapeutics IncS Sale	Chief Development Officer	SSale	−2,000 sh	$8.14	−$16.3K	95,300
2013-06-04	Trius Therapeutics IncS Sale	Chief Development Officer	SSale	−2,000 sh	$7.90	−$15.8K	97,300
2013-05-24	Trius Therapeutics IncS Sale	Chief Development Officer	SSale	−12K sh	$7.93	−$95.1K	98,927
2013-05-14	Trius Therapeutics IncS Sale	Chief Development Officer	SSale	−12K sh	$7.85	−$94.2K	98,927
2013-05-14	Trius Therapeutics IncS Sale	Chief Development Officer	SSale	−12K sh	$7.85	−$94.2K	110,927
2013-03-07	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Development Officer	AAward	+90K sh	—	—	90,000
2012-03-08	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Development Officer	AAward	+75K sh	—	—	75,000
2011-11-17	Trius Therapeutics IncS Sale	Chief Development Officer	SSale	−1,687 sh	$7.85	−$13.2K	109,844
2010-11-03	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Development Officer	AAward	+30K sh	—	—	30,000
2010-11-03	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Development Officer	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Apr 44
Cidara Therapeutics, Inc.0001209191-17-024914
SEC(opens sec.gov)
Mar 184
Cidara Therapeutics, Inc.0001209191-16-109451
SEC(opens sec.gov)
Sep 134
Trius Therapeutics Inc0001209191-13-044237
SEC(opens sec.gov)
Jul 14
Trius Therapeutics Inc0001209191-13-034397
SEC(opens sec.gov)
Jun 44
Trius Therapeutics Inc0001209191-13-030663
SEC(opens sec.gov)
May 284
Bartizal Ken0001209191-13-029245
SEC(opens sec.gov)
May 284/A
Bartizal Ken0001209191-13-029244
SEC(opens sec.gov)
May 164
Bartizal Ken0001209191-13-026743
SEC(opens sec.gov)
Mar 114
Bartizal Ken0001181431-13-016008
SEC(opens sec.gov)
Mar 124
Bartizal Ken0001181431-12-016290
SEC(opens sec.gov)
Nov 184
Bartizal Ken0001181431-11-056914
SEC(opens sec.gov)
Nov 54
Bartizal Ken0001181431-10-053870
SEC(opens sec.gov)

Companies

Address

C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101

SAN DIEGO, CA, 92121